Pure Financial Advisors
TAK icon

Pure Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Pure Financial Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
16,991
+3,416
+25% +$56.5K ﹤0.01% 534
2026
Q1 		$251K Buy
13,575
+3,047
+29% +$53.5K ﹤0.01% 497
2025
Q4 		$164K Buy
+10,528
New +$151K ﹤0.01% 524

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Pure Financial Advisors's TAK Position: Q2 2026 in Review

Pure Financial Advisors increased its Takeda Pharmaceutical (TAK) stake by 25% in Q2 2026, buying an estimated $56.5K and bringing the position to 16,991 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

Pure Financial Advisors first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Pure Financial Advisors held 16,991 shares of Takeda Pharmaceutical worth $272K as of Q2 2026.
  • Pure Financial Advisors bought 3,416 Takeda Pharmaceutical shares in Q2 2026, an estimated $56.5K.
  • Takeda Pharmaceutical made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #534 holding.
  • Pure Financial Advisors first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.